When a spouse dies, Social Security erases one of two monthly checks overnight, and the surviving partner suddenly faces a budget built for two people on income meant for one. Three dividend ETFs offer a way to rebuild that missing paycheck before the shortfall becomes a crisis.
Pfizer's 8.76% yield towers over bond alternatives as the pharma giant marks 26 straight years of unbroken dividend payments.
Uber hits $65.94, down nearly 4% from its June peak as the rideshare giant contends with mounting profit pressures and regulatory friction.
Joby Aviation drops to $6.93, a 52-week floor hit just one week after a prior low, as eVTOL certification timelines face mounting skepticism.
Grok is now competing directly with Google's Gemini and Microsoft's Copilot in enterprise productivity apps, marking a major expansion for Musk's AI chatbot.
RT @XFreeze: Grok is now available directly inside Google Workspace One add-on brings Grok into Google Sheets, Slides and Docs, where it w…
A $13 billion ETF has quietly been delivering T-bill-level returns to high-bracket investors without the monthly tax hit, and the options structure behind it sits in a regulatory gray zone that could unravel at any time.
Sponsored
Don't wait: the analyst who called NVIDIA in 2010 just revealed his top 10 AI stocks. See the full list FREE now.
Musk's endorsement signals xAI's push to position Grok as production-ready as competition from OpenAI and Anthropic intensifies.
Grok 4.5 is excellent for real-world work https://t.co/nCwRiIDruF
Software and fintech stocks rallied at Friday's close while a double-digit sell-off hit healthcare and semiconductor names, splitting the market sharply by sector.
Dow Jones jumps 200 points while Nasdaq slides 0.7%, showing the week's widening split between old-economy strength and tech weakness.
Musk signals that the AI arms race is shifting away from raw capability benchmarks toward pure cost efficiency, elevating cost-per-unit-of-intelligence as the defining competitive metric.
RT @GavinSBaker: New Pareto Frontier: Grok 4.5, SWE-1.7 and Opus 5. Intelligence per $ will be the only metric that matters over time. K3…
Regulatory headwinds over compounded GLP-1 drugs and Amazon's telehealth push are pressuring the company's margins and competitive moat in the $33.47 open price range.